Lessons From Walter Reed
Linda Bilmes, the Harvard finance expert who helped establish the true cost of the war, including veteran healthcare, turns her attention to the Walter Reed scandal, and the bureaucratic quagmire that keeps our soldiers from getting help. Bilmes offers four lessons to avoid future problems. We can only hope someone takes her advice.
Wait, before you go…Boston Globe:
Soldiers injured in theatre are supposedly able to apply for disability benefits before they are discharged. But to take advantage of the program a soldier must know when he is going to be discharged. Unfortunately, much of the force doesn’t know when it will be discharged because of repeated deployments and “stop-loss” orders. Furthermore, National Guard and Reserve soldiers are excluded from the pre-discharge program.
The bureaucratic fumbling between the Department of Defense and the Department of Veterans Affairs also diverts the VA’s stretched medical resources into claims processing and away from providing prompt, needed treatment.
Here are some simple lessons from the Walter Reed scandal that will improve the lot of the 900,000 servicemen who are still deployed into the Iraq and Afghanistan wars:
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
Support Truthdig
There are currently no responses to this article.
Be the first to respond.